Accelerate Capital Lease Obligations from 2010 to 2024
| AXDX Stock | USD 1.07 0.03 2.73% |
Capital Lease Obligations | First Reported 2019-03-31 | Previous Quarter 1.3 M | Current Value 969 K | Quarterly Volatility 1.3 M |
Check Accelerate Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Accelerate Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.4 M, Interest Expense of 8.1 M or Selling General Administrative of 35.9 M, as well as many indicators such as Price To Sales Ratio of 3.85, Dividend Yield of 2.0E-4 or Days Sales Outstanding of 75.39. Accelerate financial statements analysis is a perfect complement when working with Accelerate Diagnostics Valuation or Volatility modules.
Accelerate | Capital Lease Obligations |
Latest Accelerate Diagnostics' Capital Lease Obligations Growth Pattern
Below is the plot of the Capital Lease Obligations of Accelerate Diagnostics over the last few years. Accelerate Diagnostics capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Accelerate Diagnostics asset purchases. For example, Accelerate Diagnostics can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Accelerate Diagnostics control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. Accelerate Diagnostics' Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Accelerate Diagnostics' overall financial position and show how it may be relating to other accounts over time.
| Capital Lease Obligations | 10 Years Trend |
|
Capital Lease Obligations |
| Timeline |
Accelerate Capital Lease Obligations Regression Statistics
| Arithmetic Mean | 1,901,978 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 99.77 | |
| Mean Deviation | 1,775,179 | |
| Median | 2,392,000 | |
| Standard Deviation | 1,897,693 | |
| Sample Variance | 3.6T | |
| Range | 4.3M | |
| R-Value | 0.78 | |
| Mean Square Error | 1.5T | |
| R-Squared | 0.61 | |
| Significance | 0.0006 | |
| Slope | 331,663 | |
| Total Sum of Squares | 50.4T |
Accelerate Capital Lease Obligations History
About Accelerate Diagnostics Financial Statements
Accelerate Diagnostics investors use historical fundamental indicators, such as Accelerate Diagnostics' Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Accelerate Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capital Lease Obligations | 2.4 M | 3.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Accelerate Stock Analysis
When running Accelerate Diagnostics' price analysis, check to measure Accelerate Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accelerate Diagnostics is operating at the current time. Most of Accelerate Diagnostics' value examination focuses on studying past and present price action to predict the probability of Accelerate Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accelerate Diagnostics' price. Additionally, you may evaluate how the addition of Accelerate Diagnostics to your portfolios can decrease your overall portfolio volatility.